Strategies for the direct cloning of polymerase chain reaction (PCR) products take advantage of the terminal transferase activity of TaqDNA polymerase. Under standard PCR conditions, Taq polymerase preferentially adds an A residue to the 3 ′ end of the PCR product (3) . Thus, PCR products can be cloned directly into DNA vectors that contain complementary 3 ′ T overhangs (T-vector). T-vectors have been created by inserting DNA linkers that contain two adjacent restriction sites for either Hph I (7), Asp EI (5) or XcmI (2, 4, 6, 9) . When these vectors are digested with the corresponding restriction enzyme, the vector molecule is linearized, and each end has a 3 ′ T overhang. If digestion of these T-vectors is incomplete, then the vector can re-circularize in the ligation reaction leading to a high background of nonrecombinant transformants. To reduce the number of nonrecombinant transformants, the T-vectors were either treated with phosphatase before ligation (2, 5) or were treated with the restriction enzyme during the ligation (4). These additional steps may be problematic because phosphatase treatment of the vector requires an additional step and reduces ligation efficiency; adding a restriction enzyme to the ligation reaction prevents the cloning of PCR products that contain that restriction site.
In this report, the conditions for cloning PCR products into an XcmI Tvector were optimized so that the need to reduce the nonrecombinant background was eliminated. We observed that the percentage of recombinant transformants was greatly increased when the PCR product was purified before the ligation reaction and when a 20-fold molar excess of the purified PCR product to theXcmI T-vector was used in the ligation reaction.
To prepare the vector, the XcmI Tvector, pKRX, was constructed by inserting a 36-bp linker that contains two XcmI sites (Figure 1 ) into the Eco RI and Sal I sites of pBSIISK(+) (Stratagene, La Jolla, CA, USA). The polylinker region of this vector was sequenced from both directions to verify that the Eco RI and Sal I sites were regenerated and the lac Z reading frame was maintained. The resulting vector is 2977 bp in length. pKRX (5 µ g) was treated with 10 U of XcmI (New England Biolabs, Beverly, MA, USA) in a 50-µ L reaction that contained the recommended buffer plus 100 µ g/mL bovine serum albumin (BSA) at 37°C for at least 4 h, purified (QIAquick ™; Qiagen, Chatsworth, CA, USA), eluted in 50 µ L TE buffer (10 mM Tris-HCl, pH 7.5, 1 mM EDTA), quantified with an ultraviolet (UV)/visible (VIS) spectrophotometer (Beckman Instruments, Fullerton, CA, USA) using a conversion factor for optical density of 1 OD 260 = 50 ng/ µ L, diluted to 50 ng/ µ L with TE and stored at 4°C.
To prepare the PCR product for this study, a 606-bp product was amplified from total yeast DNA using a forward (nucleotide [nt] 895, 5 ′ -CGCATCTAT -GCACTCATCAG) and a reverse (nt 1500, 5 ′ -GGGCTATGCTAATCCCA-TAG) primer derived from the yeast gene SP011 (1) . PCR was performed in the recommended buffer (PerkinElmer, Norwalk, CT, USA) using 100 pmol of each primer, 40 ng of DNA template and 2.5 U of Taq DNA polymerase in a total reaction volume of 100 µ L. Amplification was performed in a thermal cycler equipped with a "hot-bonnet" (MJ Research, Watertown, MA, USA) as follows: 2 min at 94°C, then 35 cycles of 30 s at 94°C, 30 s at 55°C, 30 s at 72°C and an additional 7 min at 72°C after the last cycle. The PCR product was purified and quantified as above.
For DNA ligation and transformation, ligation reactions were performed in the recommended buffer (Boehringer Mannheim, Indianapolis, IN, USA) and contained 50 ng of vector DNA, the indicated amount of PCR product and 1 U of T4 DNA ligase in a total reaction volume of 10 µ L. After incubation at 16°C for at least 6 h, an aliquot of each ligation reaction was electro-transformed into DH5 αcells as suggested (BTX, San Diego, CA, USA).
To identify recombinant clones from each transformation, white bacterial colonies were picked with a sterile pipet tip, patched onto an LB master plate containing 100 µ g/mL ampicillin, 20 µ g/mL isopropyl-β -D -thiogalac - and Lac Z reverse (5 ′AGCGGAT -AACAA TTTCACACAGG) (8) . PCR products were separated on a 2% agarose gel, stained with ethidium bromide and visualized with UV light. Reactions containing nonrecombinant clones produced a 248-bp PCR product; recombinant clones produced an 854-bp (248 + 606) PCR product.
The effect of cloning a purified PCR product into pKRX is shown in Table 1 . In this experiment, an equivalent amount (estimated from gel electrophoresis) of purified or unpurified PCR product was ligated with XcmI-treated pKRX. Although the overall number of transformants was similar, the fraction of recombinant clones among the white colonies was much greater when the PCR product was purified before ligation with pKRX ( Table 1 ).
The effect of cloning an increasing amount of purified PCR product into XcmI-treated pKRX is shown in Figure  2 . Ligation reactions contained increasing amounts of purified PCR product, but a constant amount of XcmI-treated pKRX. The fraction of recombinant clones increased as the molar ratio of PCR product to vector increased. At a molar ratio of 20 to 1, the fraction of recombinant clones peaked at about 90%. Thus, the efficiency of cloning a PCR product into XcmI-treated pKRX was highly dependent on the molar ratio of purified PCR product to vector.
In summary, an XcmI T-cloning vector, pKRX, was constructed that was used to directly clone PCR products, and the conditions for its use were optimized. We observed that the fraction of recombinant clones increased 10-fold when the PCR product was purified before the ligation reaction. In addition, the fraction of recombinant clones was dependent on the molar ratio of purified PCR product to the XcmI-treated vector in the ligation reaction with an optimal ratio of 20 to 1. This general protocol has been used in our laboratories to clone PCR products ranging from 150-1500 bp in length with high efficiency. Sequence analysis of most of these clones yielded the predicted DNA sequence at the cloning site. With these conditions, the pKRX system is an inexpensive and reliable method for directly cloning PCR products. We predict that the cloning of PCR products into other T vectors will also be improved by using the conditions described in this report. The T-cloning vector pKRX can be obtained from the corresponding author or from the ATCC (Rockville, MD, USA). A common strategy for large-scale DNA sequencing is shotgun cloning. In this approach, the cloned DNA is fragmented into small pieces, which are first size-fractionated and then subcloned into a sequencing vector. From the collection of clones obtained, a random sample is chosen for sequencing. The nucleotide sequence information from individual sequence reads is then fed into a computer, which assembles sequence overlaps between contiguous clones (contigs), leading to the reconstruction of the sequence of the original cloned DNA. While this approach initially provides rapid sequence information, the utilization of more directed approaches is often needed for efficient gap closures and verification of contig assembly (1) . In the present communication, we present a method for creating universal primers for sequencing restriction fragments, which can serve as an alternative directed approach to facilitate gap closure and assembly verification in large-scale DNA sequencing projects.
The method, as outlined in Figure 1 , exploits the ability of the enzyme terminal deoxynucleotidyl transferase to add a string of T-residues at the 3 ′ end of a restriction fragment. The T-tails, along with the neighboring remanent of the restriction enzyme recognition site, can then be used to direct the synthesis of specific primers for the sequencing of the modified restriction fragment.
To test this approach, we have used a unique Pst I-Sph I DNA fragment derived from plasmid pBR322. Both Pst I and Sph I enzymes produce 3 ′ overhangs, which are the best substrates for the enzyme terminal deoxynucleotidyl transferase. Briefly, a 1315-bp fragment, produced after digestion of pBR322 DNA with both Pst I and Sph I, was extracted from an agarose gel using the Wizard ™DNA Clean-Up System (Promega, Madison, WI, USA). Ttailing of the 3 ′ overhangs, present in the DNA fragment, was performed using terminal deoxynucleotidyl transferase (Promega) in a buffer supplied by Promega containing 1 pmol of DNA, 20 pmol dTTP and 2 pmol ddTTP. The tailed DNA product was then purified with the Wizard System. For the sequencing of the tailed restric44BioTechniques
Vol. 22, No. 1 (1997) Figure 1 . Steps involved in the modification of restriction fragments for sequencing. The strategy used to sequence a Pst I-Sph I fragment derived from plasmid pBR322 is shown. UPstI and USphI denote universal primers for Pst I and Sph I restriction sites, respectively.
